$NXTC
NextCure Inc

2022 Q3 Form 10-Q Financial Statement

#000155837022012232 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.711M $5.303M $5.747M
YoY Change 16.29% -11.72% 18.49%
% of Gross Profit
Research & Development $13.53M $12.83M $15.02M
YoY Change -0.51% 7.37% 21.3%
% of Gross Profit
Depreciation & Amortization $1.021M -$1.000K $2.097M
YoY Change -51.29% -100.05% 88.92%
% of Gross Profit
Operating Expenses $19.24M $18.13M $20.77M
YoY Change 3.95% 0.98% 20.52%
Operating Profit -$19.24M -$18.13M -$20.77M
YoY Change 3.95% 0.98% 20.52%
Interest Expense $328.0K $208.0K $169.0K
YoY Change -43.25% -694.29% -75.86%
% of Operating Profit
Other Income/Expense, Net $328.0K $208.0K $169.0K
YoY Change -43.25% -694.29% -75.89%
Pretax Income -$18.91M -$17.92M -$20.60M
YoY Change 5.47% -0.37% 24.63%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$18.91M -$17.92M -$20.60M
YoY Change 5.47% -0.37% 24.61%
Net Earnings / Revenue
Basic Earnings Per Share -$0.68 -$0.65 -$0.74
Diluted Earnings Per Share -$0.68 -$0.65 -$0.74
COMMON SHARES
Basic Shares Outstanding 27.75M 27.74M 27.71M
Diluted Shares Outstanding 27.75M 27.74M 27.71M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $169.2M $185.5M $201.3M
YoY Change -28.1% -25.66% -24.94%
Cash & Equivalents $31.05M $28.16M $10.65M
Short-Term Investments $138.2M $157.3M $190.7M
Other Short-Term Assets $6.101M $7.462M $7.609M
YoY Change -20.77% -18.11% 58.52%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $175.3M $193.0M $208.9M
YoY Change -27.86% -25.39% -23.5%
LONG-TERM ASSETS
Property, Plant & Equipment $12.13M $12.62M $13.24M
YoY Change -14.66% -14.24% -14.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.469M $801.0K $574.0K
YoY Change 324.96% -60.31% -76.08%
Total Long-Term Assets $14.59M $13.42M $13.81M
YoY Change -1.32% -19.79% -22.83%
TOTAL ASSETS
Total Short-Term Assets $175.3M $193.0M $208.9M
Total Long-Term Assets $14.59M $13.42M $13.81M
Total Assets $189.9M $206.4M $222.7M
YoY Change -26.34% -25.05% -23.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.846M $2.272M $2.801M
YoY Change -37.34% 68.17% 40.05%
Accrued Expenses $3.943M $3.325M $3.411M
YoY Change -6.83% -37.78% -20.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $5.891M $5.697M $6.424M
YoY Change -20.13% -33.49% -21.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $2.477M $2.477M $2.386M
YoY Change 11.43% 11.38% 8.45%
Total Long-Term Liabilities $2.477M $2.477M $2.386M
YoY Change 11.43% 154.84% -33.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.891M $5.697M $6.424M
Total Long-Term Liabilities $2.477M $2.477M $2.386M
Total Liabilities $8.368M $8.174M $8.810M
YoY Change -12.82% -30.5% -25.34%
SHAREHOLDERS EQUITY
Retained Earnings -$244.5M -$225.5M -$207.6M
YoY Change 43.73% 48.23%
Common Stock $28.00K $28.00K $28.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $181.5M $198.2M $213.9M
YoY Change
Total Liabilities & Shareholders Equity $189.9M $206.4M $222.7M
YoY Change -26.34% -25.05% -23.45%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$18.91M -$17.92M -$20.60M
YoY Change 5.47% -0.37% 24.61%
Depreciation, Depletion And Amortization $1.021M -$1.000K $2.097M
YoY Change -51.29% -100.05% 88.92%
Cash From Operating Activities -$15.00M -$14.49M -$15.45M
YoY Change 18.47% -15.87% 11.04%
INVESTING ACTIVITIES
Capital Expenditures -$532.0K -$414.0K $305.0K
YoY Change -4.32% 98.09% -60.18%
Acquisitions
YoY Change
Other Investing Activities $18.42M $32.34M $14.01M
YoY Change 23.05% 104.69% -23.75%
Cash From Investing Activities $17.89M $31.92M $13.70M
YoY Change 24.1% 104.78% -22.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 79.00K 60.00K
YoY Change -100.0% -119.36% -116.95%
NET CHANGE
Cash From Operating Activities -15.00M -14.49M -15.45M
Cash From Investing Activities 17.89M 31.92M 13.70M
Cash From Financing Activities 0.000 79.00K 60.00K
Net Change In Cash 2.887M 17.51M -1.685M
YoY Change -428.82% -957.12% -150.52%
FREE CASH FLOW
Cash From Operating Activities -$15.00M -$14.49M -$15.45M
Capital Expenditures -$532.0K -$414.0K $305.0K
Free Cash Flow -$14.47M -$14.08M -$15.75M
YoY Change 19.52% -17.27% 7.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
426056000
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
399-4900
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31133000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
54231000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
136425000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
7889000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
102258000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
719000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
979000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45623000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33188000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
66000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.25
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27744762
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27610398
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27726864
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27603948
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001661059
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27680997
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27748844
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27744762
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27610398
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27726864
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27603948
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.25
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38905
dei Entity Registrant Name
EntityRegistrantName
NextCure, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5231247
dei Entity Address Address Line1
EntityAddressAddressLine1
9000 Virginia Manor Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Beltsville
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
76000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
73000
us-gaap Repayments Of Debt
RepaymentsOfDebt
834000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20705
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
NXTC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27748844
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28163000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12337000
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
157329000
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
207254000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
39000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
39000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7423000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8187000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
192954000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
227817000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12615000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13992000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
801000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
577000
CY2022Q2 us-gaap Assets
Assets
206370000
CY2021Q4 us-gaap Assets
Assets
242386000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2272000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1942000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3325000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4449000
CY2022Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
100000
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
217000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5697000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6608000
CY2022Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2477000
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2392000
CY2022Q2 us-gaap Liabilities
Liabilities
8174000
CY2021Q4 us-gaap Liabilities
Liabilities
9000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
233386000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27748844
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27680997
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
28000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
421047000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2340000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-663000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-225548000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-187026000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
198196000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
206370000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242386000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12825000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11945000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27849000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24331000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5303000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6007000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11050000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10855000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
18128000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
17952000
us-gaap Operating Expenses
OperatingExpenses
38899000
us-gaap Operating Expenses
OperatingExpenses
35186000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18128000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17952000
us-gaap Operating Income Loss
OperatingIncomeLoss
-38899000
us-gaap Operating Income Loss
OperatingIncomeLoss
-35186000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
208000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-35000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
377000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
666000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17920000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17987000
us-gaap Net Income Loss
NetIncomeLoss
-38522000
us-gaap Net Income Loss
NetIncomeLoss
-34520000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.25
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27744762
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27610398
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27726864
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27603948
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17920000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17987000
us-gaap Net Income Loss
NetIncomeLoss
-38522000
us-gaap Net Income Loss
NetIncomeLoss
-34520000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-141000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-374000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1677000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-974000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-758000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15826000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18061000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18361000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40199000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35494000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
233386000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2628000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
60000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2022Q1 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-1536000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-20602000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
213936000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2242000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
73000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2022Q2 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-141000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17920000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
198196000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
293721000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2508000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
63000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2021Q1 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-600000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-16533000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
279159000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2787000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2021Q2 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-374000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17987000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
263598000
us-gaap Profit Loss
ProfitLoss
-38522000
us-gaap Profit Loss
ProfitLoss
-34520000
nxtc Depreciation Depletion And Amortization And Other
DepreciationDepletionAndAmortizationAndOther
2096000
nxtc Depreciation Depletion And Amortization And Other
DepreciationDepletionAndAmortizationAndOther
1394000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1906000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1603000
us-gaap Share Based Compensation
ShareBasedCompensation
4870000
us-gaap Share Based Compensation
ShareBasedCompensation
5295000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-540000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4577000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
330000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2550000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1124000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
717000
nxtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-32000
nxtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
1505000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29936000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1297000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12376000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36284000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28202000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12376000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37581000
us-gaap Interest Paid Net
InterestPaidNet
46000
us-gaap Interest Paid Net
InterestPaidNet
67000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
666000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities as of the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting periods. Although actual results could differ from those estimates, management does not believe that such differences would be material.</p>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28163000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12337000
CY2022Q2 nxtc Restricted Cash And Other Assets Current
RestrictedCashAndOtherAssetsCurrent
39000
CY2021Q4 nxtc Restricted Cash And Other Assets Current
RestrictedCashAndOtherAssetsCurrent
39000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28202000
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
159669000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2341000
CY2022Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
157329000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
207917000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2021Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
207254000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
9000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
56000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
151300000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
33200000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
136495000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
134648000
CY2022Q2 nxtc Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost
23174000
CY2022Q2 nxtc Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
22681000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
159669000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
157329000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2242000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2787000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4870000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5295000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.797
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.797
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-17920000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17987000
us-gaap Net Income Loss
NetIncomeLoss
-38522000
us-gaap Net Income Loss
NetIncomeLoss
-34520000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27744762
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27610398
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27726864
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27603948
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.25
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5381280
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4554173
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001558370-22-012232-index-headers.html Edgar Link pending
0001558370-22-012232-index.html Edgar Link pending
0001558370-22-012232.txt Edgar Link pending
0001558370-22-012232-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nxtc-20220630.xsd Edgar Link pending
nxtc-20220630x10q.htm Edgar Link pending
nxtc-20220630x10q_htm.xml Edgar Link completed
nxtc-20220630xex31d1.htm Edgar Link pending
nxtc-20220630xex31d2.htm Edgar Link pending
nxtc-20220630xex32d1.htm Edgar Link pending
nxtc-20220630_cal.xml Edgar Link unprocessable
nxtc-20220630_def.xml Edgar Link unprocessable
nxtc-20220630_lab.xml Edgar Link unprocessable
nxtc-20220630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending